Why Is Applied Therapeutics (APLT) Stock Up 59% Today?

Applied Therapeutics (NASDAQ:APLT) stock is on the rise Wednesday after the clinical-stage biopharmaceutical company got an update from the Food and Drug Administration (FDA).The FDA has accepted the company’s New Drug Application (NDA) for govorestat as a treatment for Classic Galactosemia. It was also granted Priority Review status with a target action date of Aug. 28, 2024.To go along with this, the FDA is planning an advisory committee meeting to review the NDA for govorestat. Investors will note that t ...